CXCL5 and prostate neoplasm: observed that CXCL5 was transcriptionally unregulated in macrophages interacting with apoptotic cancer cells in contrast with noncancer cells during macrophage-driven efferocytosis, which accelerates inflammation and growth of prostate tumor metastases in bone (28).